Understanding Your CSID Diagnosis
At a Glance
Congenital Sucrase-Isomaltase Deficiency (CSID) is a genetic condition where the body lacks the digestive enzymes needed to break down sucrose and starch. This causes chronic bloating, gas, and diarrhea. Once diagnosed, CSID is highly manageable with targeted dietary changes and enzyme therapy.
If you or your child have spent months or even years searching for the cause of chronic bloating, gas, and diarrhea, finally hearing the term Congenital Sucrase-Isomaltase Deficiency (CSID) can feel both overwhelming and like a profound relief. You are not alone in this journey. CSID is a condition where the body lacks the specific tools needed to break down certain sugars and starches [1]. While the diagnosis might feel rare, it is increasingly recognized that many people have lived with these symptoms for a long time without a clear answer [2][3].
Understanding the Biological Mechanism
The human body uses specialized enzymes (proteins that act as chemical tools) to turn food into energy. In a typical digestive system, the sucrase-isomaltase (SI) complex sits on the lining of the small intestine [1][4]. Its job is to break down sucrose (table sugar) and starch (found in foods like potatoes, rice, and bread) into simple sugars that the body can absorb [1][5].
In people with CSID, these enzymes are either missing, insufficient, or don’t work correctly [6][7]. Because the body cannot break these carbohydrates down, they remain in the gut. This creates an osmotic gradient, which means the undigested sugar pulls water into the intestines [1][8]. When this mixture reaches the large intestine, natural bacteria ferment the sugar, leading to the hallmark symptoms of the condition [1][9]:
- Frequent, watery diarrhea
- Painful abdominal bloating and gas
- Stomach cramps and general discomfort
The Journey to an Answer
Many patients describe their path to diagnosis as a “diagnostic odyssey” [1]. Because the symptoms of CSID look almost identical to common issues like Irritable Bowel Syndrome (IBS) or “toddler’s diarrhea,” it is frequently misdiagnosed [10][11]. It is common for patients to undergo multiple endoscopies or colonoscopies that come back “normal” before CSID is finally identified [1][12].
Whether you are the parent of an infant who began having symptoms when starting solid foods, or an adult who has “just had a sensitive stomach” for decades, receiving this diagnosis is a turning point [9][13]. It validates that the physical distress you have experienced is real and has a biological cause.
Three Stabilizing Facts
As you begin to navigate this new reality, keep these facts in mind to help ground your family’s experience:
- The symptoms are manageable. While CSID is a lifelong condition, most patients see a significant improvement in their quality of life once they begin proper treatment, which usually involves dietary changes or enzyme replacement therapy [14][15]. Many patients notice symptom improvements within a few days of starting treatment, though complete gut healing can take longer.
- It is more common than we once thought. CSID was traditionally viewed as an extremely rare “recessive” disorder (meaning you need two faulty genes). However, research now shows that “carriers” (those with only one faulty gene) can also experience significant symptoms, meaning many more people are affected than previously realized [16][10][3].
- You didn’t cause this. CSID is a genetic condition [7]. It is not caused by lifestyle choices, poor diet, or anything you did during pregnancy or childhood. It is simply a matter of how the body was built to process nutrients [6][1].
Moving forward, the goal of care is to find the most “liberal” diet possible—one that minimizes symptoms while still allowing for a variety of foods and proper nutrition [15]. This is the start of a more predictable and comfortable chapter in your health journey.
Next steps: Recognizing Symptoms and Avoiding Misdiagnosis
In this guide
4 chapters
Recognizing Symptoms and Avoiding Misdiagnosis
Learn to recognize Congenital Sucrase-Isomaltase Deficiency (CSID) symptoms in infants and adults. Discover why it's often misdiagnosed as IBS or diarrhea.
How CSID is Diagnosed
Learn how Congenital Sucrase-Isomaltase Deficiency (CSID) is diagnosed. Understand the EGD biopsy, genetic testing for the SI gene, and breath tests.
Treatment and Dietary Management
Learn effective treatment and dietary management for Congenital Sucrase-Isomaltase Deficiency (CSID). Discover how to use sacrosidase and navigate starch limits.
Living Well with CSID
Learn how to successfully manage CSID in daily life. Discover practical tips for navigating social events, eating out, and optimizing nutritional health.
Common questions in this guide
What causes Congenital Sucrase-Isomaltase Deficiency (CSID)?
Why is CSID often misdiagnosed as IBS?
How is CSID treated and managed?
Can you have CSID symptoms if you are only a genetic carrier?
How quickly will my symptoms improve after starting CSID treatment?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How do my (or my child's) specific genetic test results or biopsy findings influence the severity of the symptoms we should expect?
- 2.Are we dealing with a complete lack of enzymes or a partial deficiency, and how does that change our dietary approach?
- 3.Since CSID symptoms often look like IBS or other conditions, how can we be sure this is the primary cause of the symptoms?
- 4.What are the first steps for adjusting our diet, and when should we consider enzyme replacement therapy?
- 5.How often should we monitor for potential nutritional deficiencies, like iron or vitamin levels, while managing this diet?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Sucrase-Isomaltase Deficiency Causing Persistent Bloating and Diarrhea in an Adult Female.
Chiruvella V, Cheema A, Arshad HMS, et al.
Cureus 2021; (13(4)):e14349 doi:10.7759/cureus.14349.
PMID: 33972906 - 2
Prevalence of congenital sucrase-isomaltase deficiency in Turkey may be much higher than the estimates.
Taskin DG, Civan HA, Sari EE, et al.
Journal of genetics 2023; (102()).
PMID: 37349966 - 3
Heterozygotes Are a Potential New Entity among Homozygotes and Compound Heterozygotes in Congenital Sucrase-Isomaltase Deficiency.
Husein DM, Wanes D, Marten LM, et al.
Nutrients 2019; (11(10)) doi:10.3390/nu11102290.
PMID: 31557950 - 4
Structural Studies of the Intestinal α-Glucosidases, Maltase-glucoamylase and Sucrase-isomaltase.
Rose DR, Chaudet MM, Jones K
Journal of pediatric gastroenterology and nutrition 2018; (66 Suppl 3()):S11-S13 doi:10.1097/MPG.0000000000001953.
PMID: 29762369 - 5
The History of Maltose-active Disaccharidases.
Lentze MJ
Journal of pediatric gastroenterology and nutrition 2018; (66 Suppl 3()):S4-S6 doi:10.1097/MPG.0000000000001960.
PMID: 29762367 - 6
Molecular pathogenicity of novel sucrase-isomaltase mutations found in congenital sucrase-isomaltase deficiency patients.
Gericke B, Amiri M, Scott CR, Naim HY
Biochimica et biophysica acta. Molecular basis of disease 2017; (1863(3)):817-826 doi:10.1016/j.bbadis.2016.12.017.
PMID: 28062276 - 7
Differential Effects of Sucrase-Isomaltase Mutants on Its Trafficking and Function in Irritable Bowel Syndrome: Similarities to Congenital Sucrase-Isomaltase Deficiency.
Husein DM, Rizk S, Naim HY
Nutrients 2020; (13(1)) doi:10.3390/nu13010009.
PMID: 33375084 - 8
ChREBP-Knockout Mice Show Sucrose Intolerance and Fructose Malabsorption.
Kato T, Iizuka K, Takao K, et al.
Nutrients 2018; (10(3)) doi:10.3390/nu10030340.
PMID: 29534502 - 9
Congenital sucrase-isomaltase deficiency in Türkiye; a single center experience.
Barut D, Kıran Taşcı E, Kunay B, et al.
Scandinavian journal of gastroenterology 2024; (59(6)):647-651 doi:10.1080/00365521.2024.2324961.
PMID: 38459691 - 10
Sucrase-isomaltase Gene Variants in Patients With Abnormal Sucrase Activity and Functional Gastrointestinal Disorders.
Deb C, Campion S, Derrick V, et al.
Journal of pediatric gastroenterology and nutrition 2021; (72(1)):29-35 doi:10.1097/MPG.0000000000002852.
PMID: 32732636 - 11
Exploring congenital sucrase-isomaltase deficiency in autism spectrum disorder patients with irritable bowel syndrome symptoms: A prospective SI gene sequencing study.
Zubarioglu T, Ulgen D, Akca-Yesil S, et al.
Autism research : official journal of the International Society for Autism Research 2025; (18(1)):44-55 doi:10.1002/aur.3293.
PMID: 39676735 - 12
Prevalence of Disaccharidase Deficiency in Adults With Unexplained Gastrointestinal Symptoms.
Viswanathan L, Rao SSC, Kennedy K, et al.
Journal of neurogastroenterology and motility 2020; (26(3)):384-390 doi:10.5056/jnm19167.
PMID: 32380581 - 13
Intestinal Disaccharidase Deficiency in Adults: Evaluation and Treatment.
Viswanathan L, Rao SS
Current gastroenterology reports 2023; (25(6)):134-139 doi:10.1007/s11894-023-00870-z.
PMID: 37199899 - 14
The patient journey to diagnosis and treatment of congenital sucrase-isomaltase deficiency.
Smith H, Romero B, Flood E, Boney A
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2021; (30(8)):2329-2338 doi:10.1007/s11136-021-02819-z.
PMID: 33772704 - 15
Demystifying Carbohydrate Maldigestion: A Clinical Review.
Cash BD, Patel D, Scarlata K
The American journal of gastroenterology 2025; (120(4S)):1-11 doi:10.14309/ajg.0000000000003374.
PMID: 40249016 - 16
Congenital Sucrase-Isomaltase Deficiency: Same Mutation with Different Clinical Presentations.
İryancı Fİ, Güven B, Çakır M
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2024; (35(4)):343-349 doi:10.5152/tjg.2024.23250.
PMID: 39128102
This page provides educational information about Congenital Sucrase-Isomaltase Deficiency (CSID). It is not a substitute for professional medical advice, diagnosis, or dietary treatment plans from your gastroenterologist or registered dietitian.
Get notified when new evidence is published on Congenital sucrase-isomaltase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.